Clinical Trial News and Research

RSS

UAB-led clinical trial intends to find innovative treatment for multiple myeloma patients

Multiple myeloma is the second most common type of blood cancer in the United States, impacting more than 25,000 people each year and disproportionatly affecting African-American men.

15 May 2018

ICON and DuPage Medical Group announce clinical research partnership

ICON plc, a global provider of drug development and commercialization solutions and services, today announced that PMG Research, Inc., part of ICON Site and Patient Recruitment, and DuPage Medical Group of Chicago, Illinois have finalized a Master Agreement formalizing a clinical research partnership.

14 May 2018

Doctors use new non-invasive approach to treat nasal obstruction

Researchers at The Ohio State University Wexner Medical Center are exploring how small changes in the nasal cavity impact airflow and quality of life.

14 May 2018

FDA approves new drug to treat MS in pediatric patients

The U.S. Food and Drug Administration today approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in children and adolescents age 10 years and older. This is the first FDA approval of a drug to treat MS in pediatric patients.

14 May 2018

HPV vaccine for girls gets thumbs up from Cochrane review

According to a Cochrane review that was released recently, the HPV vaccine, that can protect girls and young women from Human Papilloma virus (HPV) can help protect them against cancer of the cervix later in life. The report appears in the latest issue of the Cochrane Database of Systematic Reviews.

13 May 2018

Adding chemotherapy to treatment regimen can give children with PVS a chance to grow up

Pulmonary vein stenosis (PVS) is a rare disease in which abnormal cells build up inside the veins responsible for carrying oxygen-rich blood from the lungs to the heart. It restricts blood flow through these vessels, eventually sealing them off entirely if left untreated.

11 May 2018

$Osteoporosis drug may be cardioprotective in hip fracture patients$

Osteoporosis drug may be cardioprotective in hip fracture patients

The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular death, heart attack, and stroke in a Journal of Bone and Mineral Research study of patients with hip fractures. The association was seen for up to 10 years after fracture.

11 May 2018

New survey shows 80% of oncologists have discussed medical marijuana use with patients

Data from a new survey show that as many as 80% of oncologists have discussed medical marijuana use with their patients.

11 May 2018

New therapeutic strategy exploits acquired vulnerability in drug-resistant cancer

Cancer cells that develop resistance to drugs, pay a price for this, by simultaneously developing a new vulnerability. If this acquired vulnerability can be identified, it may be exploited clinically.

10 May 2018

CMS approves national reimbursement coverage for CardiAMP Chronic Myocardial Ischemia Trial

BioCardia, Inc., a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that the Centers for Medicare and Medicaid Services has approved national reimbursement coverage for the CardiAMP Chronic Myocardial Ischemia Trial.

10 May 2018

New technology detects the 'glow' to guide brain tumor resection

Research by Barrow Neurological Institute physicians and University of Washington scientists on novel imaging technology for malignant brain tumors was published in the April issue of World Neurosurgery.

10 May 2018

HCI announces opening of Center for HOPE for improving health among underserved populations

Huntsman Cancer Institute at the University of Utah today announced the opening of the Cancer Population Sciences and Huntsman Center for Health Outcomes and Population Equity, a new research and clinical space dedicated to preventing cancer and improving health among underserved populations and improving outcomes in cancer patients.

9 May 2018

ICON announces results of new survey that examines key challenge of R&D efficiency

ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the results from a new survey of pharmaceutical executives and professionals by ICON and Pharma Intelligence, which examines the key challenge of declining research and development efficiency

9 May 2018

Huntsman Cancer Institute opens Cancer Population Sciences and Huntsman Center for HOPE

Huntsman Cancer Institute (HCI) at the University of Utah (U of U) today announced the opening of the Cancer Population Sciences and Huntsman Center for Health Outcomes and Population Equity (HOPE), a new research and clinical space dedicated to preventing cancer and improving health among underserved populations and improving outcomes in cancer patients.

9 May 2018

Study compares effectiveness of vaginal estradiol tablets and moisturizers in treating vulvovaginal problems

A new study reports that vaginal estradiol tablets just might be what's needed to relieve vulvovaginal problems and improve overall quality of life.

9 May 2018

Flushing the bladder with common chemotherapy drug after surgery can reduce bladder cancer recurrence

Flushing the bladder with a common chemotherapy drug immediately after surgery significantly reduces the chances of bladder cancer returning, according to a major study by SWOG, an international clinical trials network funded by the National Cancer Institute.

9 May 2018

Increased water intake does not slow loss of kidney function in CKD patients

A new study, published in JAMA by researchers at Lawson Health Research Institute and Western University, found that coaching patients with Chronic Kidney Disease (CKD) to drink more water does not slow down the decline of their kidney function.

8 May 2018

Neon Therapeutics evaluates safety, efficacy of NEO-PV-01 in combination with KEYTRUDA and chemotherapy

Neon Therapeutics, a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced that it has treated the first patient in a clinical trial evaluating its proprietary personal neoantigen vaccine, NEO-PV-01, in combination with Merck's anti-PD-1 therapy, KEYTRUDA®, along with chemotherapy.

8 May 2018

FDA grants approval for two drugs administered together to treat aggressive form of thyroid cancer

The U.S. Food and Drug Administration approved Tafinlar (dabrafenib) and Mekinist (trametinib), administered together, for the treatment of anaplastic thyroid cancer (ATC) that cannot be removed by surgery or has spread to other parts of the body (metastatic), and has a type of abnormal gene, BRAF V600E (BRAF V600E mutation-positive).

8 May 2018

EPO's neuroprotective effect in preemies may be mediated by epigenetic regulation of genes

Erythropoietin helps to protect and repair vulnerable brains though it remains a mystery how the anemia drug does so.

7 May 2018

Clinical Trial News and Research

UAB-led clinical trial intends to find innovative treatment for multiple myeloma patients

ICON and DuPage Medical Group announce clinical research partnership

Doctors use new non-invasive approach to treat nasal obstruction

FDA approves new drug to treat MS in pediatric patients

HPV vaccine for girls gets thumbs up from Cochrane review

Adding chemotherapy to treatment regimen can give children with PVS a chance to grow up

Osteoporosis drug may be cardioprotective in hip fracture patients

New survey shows 80% of oncologists have discussed medical marijuana use with patients

New therapeutic strategy exploits acquired vulnerability in drug-resistant cancer

CMS approves national reimbursement coverage for CardiAMP Chronic Myocardial Ischemia Trial

New technology detects the 'glow' to guide brain tumor resection

HCI announces opening of Center for HOPE for improving health among underserved populations

ICON announces results of new survey that examines key challenge of R&D efficiency

Huntsman Cancer Institute opens Cancer Population Sciences and Huntsman Center for HOPE

Study compares effectiveness of vaginal estradiol tablets and moisturizers in treating vulvovaginal problems

Flushing the bladder with common chemotherapy drug after surgery can reduce bladder cancer recurrence

Increased water intake does not slow loss of kidney function in CKD patients

Neon Therapeutics evaluates safety, efficacy of NEO-PV-01 in combination with KEYTRUDA and chemotherapy

FDA grants approval for two drugs administered together to treat aggressive form of thyroid cancer

EPO's neuroprotective effect in preemies may be mediated by epigenetic regulation of genes

Event guide: 15th World Clinical Biomarkers & CDx Europe eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer